These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21597977)

  • 1. Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case.
    Goldfeld DA; Verna EC; Lefkowitch J; Swaminath A
    Dig Dis Sci; 2011 Nov; 56(11):3386-8. PubMed ID: 21597977
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.
    Cravo M; Silva R; Serrano M
    BioDrugs; 2010 Dec; 24 Suppl 1():25-7. PubMed ID: 21175232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report.
    Doyle A; Forbes G; Kontorinis N
    J Crohns Colitis; 2011 Jun; 5(3):253-5. PubMed ID: 21575891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
    Haennig A; Bonnet D; Thebault S; Alric L
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease.
    Salar A; Bessa X; Muñiz E; Monfort D; Besses C; Andreu M
    Gut; 2007 Aug; 56(8):1169-70. PubMed ID: 17344276
    [No Abstract]   [Full Text] [Related]  

  • 6. Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial.
    Van Assche G; Vermeire S; Ballet V; Gabriels F; Noman M; D'Haens G; Claessens C; Humblet E; Vande Casteele N; Gils A; Rutgeerts P
    Gut; 2012 Feb; 61(2):229-34. PubMed ID: 21948942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease.
    van Casteren-Messidoro C; Prins G; van Tilburg A; Zelinkova Z; Schouten J; de Man R
    J Crohns Colitis; 2012 Jun; 6(5):630-1. PubMed ID: 22398075
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease.
    Steenholdt C; Svenson M; Bendtzen K; Thomsen OØ; Brynskov J; Ainsworth MA
    J Crohns Colitis; 2012 Feb; 6(1):108-11. PubMed ID: 22261535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
    Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
    Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
    [No Abstract]   [Full Text] [Related]  

  • 10. Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature.
    Verma S; Kroeker KI; Fedorak RN
    BMC Gastroenterol; 2013 Apr; 13():59. PubMed ID: 23556424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.
    Panaccione R; Loftus EV; Binion D; McHugh K; Alam S; Chen N; Guerette B; Mulani P; Chao J
    Can J Gastroenterol; 2011 Aug; 25(8):419-25. PubMed ID: 21912766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study.
    Zorzi F; Zuzzi S; Onali S; Calabrese E; Condino G; Petruzziello C; Ascolani M; Pallone F; Biancone L
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1397-407. PubMed ID: 22519466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF antibody therapy in Crohn's disease: the risk of a switch.
    Ricart E; Ordás I; Panés J
    Gut; 2012 Feb; 61(2):169-70. PubMed ID: 22068167
    [No Abstract]   [Full Text] [Related]  

  • 14. The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy.
    Lichtiger S; Binion DG; Wolf DC; Present DH; Bensimon AG; Wu E; Yu AP; Cardoso AT; Chao J; Mulani PM; Lomax KG; Kent JD
    Aliment Pharmacol Ther; 2010 Nov; 32(10):1228-39. PubMed ID: 20955442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab for Crohn's disease after infliximab treatment failure: a systematic review.
    Da W; Zhu J; Wang L; Lu Y
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):885-91. PubMed ID: 23817447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.
    Miranda-Bautista J; Menchén L
    Gastroenterol Hepatol; 2019 May; 42(5):306-307. PubMed ID: 30029925
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.
    Subramaniam K; Chitturi S; Brown M; Pavli P
    Inflamm Bowel Dis; 2011 Nov; 17(11):E149-50. PubMed ID: 21987301
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
    J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.
    Broge T; Nguyen N; Sacks A; Davis M
    Inflamm Bowel Dis; 2013 Apr; 19(5):E75-7. PubMed ID: 23435403
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient menorrhagia without adalimumab discontinuation in a patient with Crohn's disease.
    Katsanos KH; Tsianos VE; Tsianos EV
    J Crohns Colitis; 2010 Sep; 4(3):348. PubMed ID: 21122527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.